Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape

An Update

Mônica R. Gadelha, Leandro Kasuki, Dawn S.T. Lim, Maria Fleseriu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Acromegaly is a chronic systemic disease with many complications and is associated with increased mortality when not adequately treated. Substantial advances in acromegaly treatment, as well as in the treatment of many of its complications, mainly diabetes mellitus, heart failure, and arterial hypertension, were achieved in the last decades. These developments allowed change in both prevalence and severity of some acromegaly complications and furthermore resulted in a reduction of mortality. Currently, mortality seems to be similar to the general population in adequately treated patients with acromegaly. In this review, we update the knowledge in complications of acromegaly and detail the effects of different acromegaly treatment options on these complications. Incidence of mortality, its correlation with GH (cumulative exposure vs last value), and IGF-I levels and the shift in the main cause of mortality in patients with acromegaly are also addressed.

Original languageEnglish (US)
Pages (from-to)268-332
Number of pages65
JournalEndocrine Reviews
Volume40
Issue number1
DOIs
StatePublished - Feb 1 2019

Fingerprint

Acromegaly
Mortality
Therapeutics
Diabetes Complications
Insulin-Like Growth Factor I
Chronic Disease
Heart Failure
Hypertension
Incidence
Population

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape : An Update. / Gadelha, Mônica R.; Kasuki, Leandro; Lim, Dawn S.T.; Fleseriu, Maria.

In: Endocrine Reviews, Vol. 40, No. 1, 01.02.2019, p. 268-332.

Research output: Contribution to journalArticle

Gadelha, Mônica R. ; Kasuki, Leandro ; Lim, Dawn S.T. ; Fleseriu, Maria. / Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape : An Update. In: Endocrine Reviews. 2019 ; Vol. 40, No. 1. pp. 268-332.
@article{ca3150dea7f6411a862276f65c05ad5e,
title = "Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update",
abstract = "Acromegaly is a chronic systemic disease with many complications and is associated with increased mortality when not adequately treated. Substantial advances in acromegaly treatment, as well as in the treatment of many of its complications, mainly diabetes mellitus, heart failure, and arterial hypertension, were achieved in the last decades. These developments allowed change in both prevalence and severity of some acromegaly complications and furthermore resulted in a reduction of mortality. Currently, mortality seems to be similar to the general population in adequately treated patients with acromegaly. In this review, we update the knowledge in complications of acromegaly and detail the effects of different acromegaly treatment options on these complications. Incidence of mortality, its correlation with GH (cumulative exposure vs last value), and IGF-I levels and the shift in the main cause of mortality in patients with acromegaly are also addressed.",
author = "Gadelha, {M{\^o}nica R.} and Leandro Kasuki and Lim, {Dawn S.T.} and Maria Fleseriu",
year = "2019",
month = "2",
day = "1",
doi = "10.1210/er.2018-00115",
language = "English (US)",
volume = "40",
pages = "268--332",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape

T2 - An Update

AU - Gadelha, Mônica R.

AU - Kasuki, Leandro

AU - Lim, Dawn S.T.

AU - Fleseriu, Maria

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Acromegaly is a chronic systemic disease with many complications and is associated with increased mortality when not adequately treated. Substantial advances in acromegaly treatment, as well as in the treatment of many of its complications, mainly diabetes mellitus, heart failure, and arterial hypertension, were achieved in the last decades. These developments allowed change in both prevalence and severity of some acromegaly complications and furthermore resulted in a reduction of mortality. Currently, mortality seems to be similar to the general population in adequately treated patients with acromegaly. In this review, we update the knowledge in complications of acromegaly and detail the effects of different acromegaly treatment options on these complications. Incidence of mortality, its correlation with GH (cumulative exposure vs last value), and IGF-I levels and the shift in the main cause of mortality in patients with acromegaly are also addressed.

AB - Acromegaly is a chronic systemic disease with many complications and is associated with increased mortality when not adequately treated. Substantial advances in acromegaly treatment, as well as in the treatment of many of its complications, mainly diabetes mellitus, heart failure, and arterial hypertension, were achieved in the last decades. These developments allowed change in both prevalence and severity of some acromegaly complications and furthermore resulted in a reduction of mortality. Currently, mortality seems to be similar to the general population in adequately treated patients with acromegaly. In this review, we update the knowledge in complications of acromegaly and detail the effects of different acromegaly treatment options on these complications. Incidence of mortality, its correlation with GH (cumulative exposure vs last value), and IGF-I levels and the shift in the main cause of mortality in patients with acromegaly are also addressed.

UR - http://www.scopus.com/inward/record.url?scp=85060392719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060392719&partnerID=8YFLogxK

U2 - 10.1210/er.2018-00115

DO - 10.1210/er.2018-00115

M3 - Article

VL - 40

SP - 268

EP - 332

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 1

ER -